STONY BROOK, NY--(Marketwired - July 07, 2016) - Applied DNA Sciences, Inc. (Applied DNA) (NASDAQ: APDN), a provider of DNA-based supply chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions, has entered into a two-year agreement with R&R Partnership Enterprises Incorporated ("R&R"), a company that provides document authentication services, including its ProveWrite™ document authentication system, for use in the private and public sectors. R&R will purchase DNA taggants from Applied DNA for use with the ProveWrite Program and Applied DNA will provide training and other needed support to assist in the marketing and sales of "ProveWrite Powered by Applied DNA Sciences."

Stated Robert Saenz, President of R&R, "We are happy to be working with Applied DNA Sciences. The addition of Applied DNA taggants to our ProveWrite system of document integrity and authentication provides unquestionable results where there can be no question."

R&R intends to market its proprietary authentication system and services nationwide protecting evidentiary processes, sensitive government documents, valuable municipal permits and chain of custody evidentiary processes. This Agreement will allow R&R to provide federal, state and municipal governments as well as private sector companies with the ultimate protection from document fraud, document theft and document counterfeiting.

"Our SigNature DNA taggants are a valuable asset in helping to protect forensic evidence and sensitive documents," said Dr. James Hayward, President and CEO of Applied DNA Sciences."We are proud to be working with R&R, a company whose founders are former New York City Police Department Crime Scene Unit Detectives who saw the need for better protection and authentication in their line of work.We are glad that our product has met their high standards and will be put to work to help authenticate documents and detect fraud in both the public and private sectors."

R&R is registered as a Veteran Owned Business and a Service Disabled Veteran Owned Business and its principals maintain a combined 40+ years of experience in forensics crime scene investigation and are New York State Supreme Court declared experts in testimony regarding chain of custody and evidentiary process and proceedings.

About Applied DNA Sciences

We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature® DNA describes the platform ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Go to adnas.comfor more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.

Forward-Looking Statements

The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015,and our subsequent quarterly reports on Form 10-Q filed on February 10, 2016 and May 12, 2016 which are available at APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Contact Information:

Investor contact:
Debbie Bailey

media contact:

Susan Forman
Dian Griesel Int'l.

program contact:

Michael Nizich

twitter: @APDN